RCAMU
AMPH icon

Rothschild & Co Asset Management US’s Amphastar Pharmaceuticals AMPH Stock Holding History

Rothschild & Co Asset Management US’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-224,946
Closed -$4.52M – 274
2020
Q4 		$4.52M Sell
224,946
-18,963
-8% -$369K 0.06% 232
2020
Q3 		$4.57M Sell
243,909
-41,436
-15% -$834K 0.08% 240
2020
Q2 		$6.41M Buy
285,345
+1,017
+0.4% +$18.6K 0.09% 250
2020
Q1 		$4.22M Sell
284,328
-49,461
-15% -$861K 0.07% 259
2019
Q4 		$6.44M Sell
333,789
-13,518
-4% -$259K 0.07% 275
2019
Q3 		$6.89M Sell
347,307
-216
-0.1% -$4.5K 0.07% 271
2019
Q2 		$7.34M Buy
347,523
+33,957
+11% +$710K 0.08% 273
2019
Q1 		$6.41M Sell
313,566
-22,364
-7% -$501K 0.07% 280
2018
Q4 		$6.68M Buy
335,930
+13,757
+4% +$271K 0.08% 281
2018
Q3 		$6.2M Sell
322,173
-6,668
-2% -$119K 0.06% 294
2018
Q2 		$5.02M Buy
328,841
+13,157
+4% +$230K 0.05% 301
2018
Q1 		$5.92M Sell
315,684
-10,653
-3% -$200K 0.07% 282
2017
Q4 		$6.28M Sell
326,337
-27,716
-8% -$518K 0.07% 274
2017
Q3 		$6.33M Sell
354,053
-6,527
-2% -$107K 0.07% 269
2017
Q2 		$6.44M Sell
360,580
-263,974
-42% -$4.19M 0.07% 273
2017
Q1 		$9.06M Buy
+624,554
New +$9.82M 0.1% 252

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Rothschild & Co Asset Management US's AMPH Position: Q1 2021 in Review

Rothschild & Co Asset Management US sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2021, closing a stake of 224,946 shares — an estimated $4.52M sold.

Rothschild & Co Asset Management US first reported a position in AMPH in Q1 2017 and held it in 16 quarters. The position peaked at $9.06M in Q1 2017. 135 funds tracked by Wall St. Rank hold AMPH as of Q1 2021.

  • Rothschild & Co Asset Management US reported no remaining Amphastar Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 224,946 Amphastar Pharmaceuticals shares in Q1 2021, an estimated $4.52M.
  • Rothschild & Co Asset Management US first reported a position in Amphastar Pharmaceuticals in Q1 2017 and held it in 16 quarters.
  • Rothschild & Co Asset Management US's Amphastar Pharmaceuticals position peaked at $9.06M in Q1 2017.
  • 135 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2021.

Based on Rothschild & Co Asset Management US's 13F filing for Q1 2021, filed 14 May 2021.